Everett Neville sold $497k of CI
See Remarks at Cigna Group. 1,719 shares at an average of $288.91, traded Mar 2, 2026, filed Mar 3, 2026.
Score components
- +15RoleOfficer
- +18Trade size$497k at market
- +5Share of holdings soldSold 23% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -4.4%, 3m -3.4%, 6m +0.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001739940-26-000016, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | AGrant or award Common Stock, $.01 Par Value10b5-1 | +2,602 | $0.00 | $0 | 6,111 | Mar 3, 2026 |
| Feb 27, 2026 | AGrant or award Common Stock, $.01 Par Value10b5-1 | +2,678 | $0.00 | $0 | 8,789 | Mar 3, 2026 |
| Feb 27, 2026 | FTax withholding Common Stock, $.01 Par Value10b5-1 | -883 | $287.55 | $254k | 7,906 | Mar 3, 2026 |
| Feb 27, 2026 | FTax withholding Common Stock, $.01 Par Value10b5-1 | -517 | $287.55 | $149k | 7,389 | Mar 3, 2026 |
| Mar 2, 2026 | SOpen-market sale Common Stock, $.01 Par Value10b5-1 | -1,719 | $288.91 | $497k | 5,670 | Mar 3, 2026 |
| Feb 27, 2026 | AGrant or award Employee Stock Option (Right to Buy)derivative10b5-1 | +4,127 | $0.00 | $0 | 4,127 | Mar 3, 2026 |
Related signals
Other insiders at Cigna Group and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | Cigna Group | Everett Neville See Remarks | $175k 617 shares | -11% | |
| 16Weak | Cigna Group | Nicole S Jones See Remarks | $749k 2,677 shares | -9% | |
| 15Weak | Cigna Group | Nicole S Jones See Remarks | $5.4M 19,436 shares | -42% | |
| 23Weak | CIsell Cigna Group | Jamie G Kates Chief Accounting Officer | $268k 899 shares | -28% | |
| 35Weak | Cigna Group | David Cordani Chairman & CEO | $59M 201,878 shares | -85% | |
| 23Weak | Cigna Group | Nicole S Jones See Remarks | $667k 2,307 shares | -7% | |
| 64Notable | CIbuy Cigna Group | David Cordani Chairman & CEO | $1000k 4,134 shares | +3% | |
| 5Weak | Cigna Group | Brian C Evanko See Remarks | $1.6M 5,368 shares | -9% | |
| 25Weak | Cigna Group | Nicole S Jones See Remarks | $8.6M 28,526 shares | -53% | |
| 26Weak | Cigna Group | Elder Granger director | $737k 2,376 shares | -30% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.